ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
14.94
+0.36 (2.47%)
Jul 31, 2026, 4:00 PM EDT - Market closed

ClearPoint Neuro Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
448402425167208266
Market Cap Growth
50.15%-5.41%153.75%-19.59%-21.60%-1.98%
Enterprise Value
476.04414.07408.22158.19182.68223.71
Last Close Price
14.9413.6815.386.798.4711.22

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.0310.8713.536.9910.1316.29
PB Ratio
23.7814.3416.737.915.645.44
P/TBV Ratio
-58.4616.377.895.554.77

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.7211.2013.006.608.8913.73

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
3.362.050.120.640.310.24
Net Debt / Equity Ratio
1.490.44-0.65-0.43-0.69-0.86
Net Debt / EBITDA Ratio
-1.09-0.530.880.421.593.17
Net Debt / FCF Ratio
-1.05-0.501.790.641.553.25
Asset Turnover
0.420.540.770.490.340.34
Inventory Turnover
1.811.881.661.200.991.27
Quick Ratio
4.674.872.403.555.9211.88
Current Ratio
5.795.913.224.877.5413.02
Return on Equity (ROE)
-124.05%-95.64%-81.24%-76.09%-38.37%-56.33%
Return on Assets (ROA)
-27.78%-35.37%-48.25%-45.74%-26.98%-28.13%
Return on Invested Capital (ROIC)
-60.93%-98.48%-189.62%-192.19%-178.04%-200.21%
Return on Capital Employed (ROCE)
-30.98%-41.73%-61.60%-53.49%-29.82%-30.69%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-4.27%-4.76%-9.85%-1.75%-16.63%-30.82%
Total Shareholder Return
-4.27%-4.76%-9.85%-1.75%-16.63%-30.82%
SEC Filings: 10-K · 10-Q